loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: (E)-N-Hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino)methyl)phenyl)acrylamide 2-hydroxypropanoate

    Menu

    (E)-N-Hydroxy-3-(4-(((2-(2-methyl-1H-indol-3-yl)ethyl)amino)methyl)phenyl)acrylamide 2-hydroxypropanoate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 205353 / DOSAGE - CAPSULE;ORAL - EQ 15MG BASE

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    PANOBINOSTAT LACTATE(UNII: HN0T99OO4V)
    (PANOBINOSTAT - UNII:9647FM7Y3Z)     		PANOBINOSTAT20mg | 15mg | 10mg

    Inactive Ingredients

    Ingredient Name
    Novartis Pharmaceuticals Corporation
    CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
    MAGNESIUM STEARATE(70097M6I30)
    MANNITOL(3OWL53L36A)
    STARCH, CORN(O8232NY3SJ)